| 乌司他丁与奥曲肽治疗急性胰腺炎的经济学评价 |
| 投稿时间：2004-11-23 点此下载全文 |
| 引用本文：郑继海,王金彩,卢光洲.乌司他丁与奥曲肽治疗急性胰腺炎的经济学评价[J].药学实践杂志,2005,(2):103~104 |
| 摘要点击次数: 1690 |
| 全文下载次数: 1013 |
|
|
| 中文摘要:目的 评价国产乌司他丁(天普洛安)与进口奥曲肽(善宁)治疗轻症急性胰腺炎的经济效果.方法 回顾41例轻症急性胰腺炎患者,按治疗药物的不同分为乌司他丁组、进口奥曲肽(善宁)组,运用药物经济学中的最小成本分析方法进行评价.结果 两组治疗效果差异无显著性,但进口奥曲肽组的治疗费用明显高于乌司他丁组.结论 国产乌司他丁治疗急性胰腺炎费用低,效果满意. |
| 中文关键词:乌司他丁 奥曲肽 胰腺炎 急性 最小成本分析 |
| |
| Economic evaluation of ulinastatin vs octreotide in treatment of acute pancreatitis |
|
|
| Abstract:Objective To evaluate the economic effectiveness of domestic ulinastatin and sandostain in the treatment of acute pancreatitis. Methods 41 cases with acute pancreatitis were divided into 2 groups according to the therapeutic drug: the ulinastatin group and the sandostain group. The two groups were compared by cost-minimization analysis of pharmacoeconomics. Results There is no significant difference in clinical therapeutic effect between two groups, but the cost of the sandostain group is much higher than the ulinastatin group. Conclusion The cost of domestic ulinastatin is minimization. |
| keywords:ulinastatin sandostain pancreatitis acute cost-minimization analysis |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
